Skip to search formSkip to main contentSkip to account menu

Maxmarvil

National Institutes of Health

Related topics

Related topics

3 relations

Broader (3)

AlendronateCalcitriolDrug Combinations

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Impact on Bisphosphonate Persistence and Compliance: Daily Postprandial Administration
Background Bisphosphonate (BP) is an effective drug for the prevention and treatment of osteoporosis. However, gastrointestinal… 
2017
2017
Fracture Preventing Effects of Maxmarvil® Tablets (Alendronate 5 mg + Calcitriol 0.5 µg) in Patients with Osteoporosis
Background The purpose of this prospective, open-label, observational study was to assess the fracture preventing effect of… 
2013
2013
Endoscopic comparison of alendronate alone and the enteric-coated alendronate with calcitriol combination in postmenopausal Korean females
Background/Aims This study was performed to compare the mucosal findings after esophagogastroduodenoscopy in two groups before… 
2013
2013
Improved dosage form of the combined alendronate and calcitriol (Maxmarvil®) on the absorption of alendronate in Korean postmenopausal women
Alendronate is one of the most potent anti-osteoporotic agents for postmenopausal osteoporosis. However, high doses of… 
2013
2013
Pharmacokinetic study of alendronate plus calcitriol (Maxmarvil ®) in Korean healthy postmenopausal women
2010
2010
The Effects of Combined Treatment of Alendronate Plus Active or Plain Vitamin D on the Vitamin D Metabolism and Bone Turnover Markers in Patients with Osteoporosis
®(alendronate 5 mg plus calcitriol 0.5 µg) daily or Fosamax Plus ® (alendronate 70 mg plus cholecalciferol 2,800 IU) weekly for 1… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)